Q9PU13
Gene name |
spdya-a |
Protein name |
Speedy protein 1-A |
Names |
Spy1-A, Protein Ls26, Rapid inducer of G2/M progression in oocytes A, RINGO-A, XSpy1-A, p33 ringo-A, xRINGO-A |
Species |
Xenopus laevis (African clawed frog) |
KEGG Pathway |
xla:398012 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9PU13
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9PU13-F1 | Predicted | AlphaFoldDB |
No variants for Q9PU13
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q9PU13 | |||||
No associated diseases with Q9PU13
No regional properties for Q9PU13
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q9PU13 | |||
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| cyclin binding | Binding to cyclins, proteins whose levels in a cell varies markedly during the cell cycle, rising steadily until mitosis, then falling abruptly to zero. As cyclins reach a threshold level, they are thought to drive cells into G2 phase and thus to mitosis. |
| protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
6 GO annotations of biological process
| Name | Definition |
|---|---|
| G2/MI transition of meiotic cell cycle | The cell cycle process in which a cell progresses from meiotic G2 phase to M phase of meiosis I. |
| mRNA polyadenylation | The enzymatic addition of a sequence of 40-200 adenylyl residues at the 3' end of a eukaryotic mRNA primary transcript. |
| oocyte maturation | A developmental process, independent of morphogenetic (shape) change, that is required for an oocyte to attain its fully functional state. Oocyte maturation commences after reinitiation of meiosis commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization. |
| positive regulation of cyclin-dependent protein serine/threonine kinase activity | Any process that activates or increases the frequency, rate or extent of CDK activity. |
| positive regulation of MAPK cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
| positive regulation of meiotic cell cycle | Any process that activates or increases the frequency, rate or extent of progression through the meiotic cell cycle. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MRHMQSVTRA | TSICGSGVKQ | VIGKGHPHAR | VVGARKARIP | EREELSVKPK | MVRNTHLNLQ |
| 70 | 80 | 90 | 100 | 110 | 120 |
| PQERQAFYRL | LENEQIQEFL | SMDSCLRISD | KYLIAMVLAY | FKRAGLYTSE | YTTMNFFVAL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| YLANDMEEDE | EDYKYEIFPW | ALGDSWRELF | PQFLRLRDDF | WAKMNYRAVV | SRRCCDEVMS |
| 190 | 200 | 210 | 220 | 230 | 240 |
| KDPTHWAWLR | DRPIHHSGAM | RGYLRNEDDF | SPRGPGLTPA | SCTLCHKAGV | CDSGGVSHNN |
| 250 | 260 | 270 | 280 | 290 | |
| SSSPEQEIFH | YTNREWSQEL | LMLSPELLLD | PECTHDLHIL | QEPLVGLEPD | GTALEWHHL |